NCT03360331

Brief Summary

Evaluation of the calcifying effect of phosphorus on vascular smooth muscle and detect the association between serum phosphorus and valvular and vascular calcification in end stage renal disease patients

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2017

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2017

Completed
26 days until next milestone

Study Start

First participant enrolled

December 1, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 4, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

December 4, 2017

Status Verified

October 1, 2017

Enrollment Period

11 months

First QC Date

November 5, 2017

Last Update Submit

November 30, 2017

Conditions

Vascular Calcification

Outcome Measures

Primary Outcomes (1)

  • Decrease the cardiovascular complications in ESRD patients

    Find the relationship between phosphorus and valvular and vascular calcification in ESRD PATIENTS

    one year

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

ESRD patients on regular dialysis for five years duration aging 18 to40 years old

You may qualify if:

  • ESRD patients on regular dialysis of five years duration aging 18 to 40 years

You may not qualify if:

  • patients with hypercalcemia or hyperlipidemia or diabetic patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Vascular Calcification

Condition Hierarchy (Ancestors)

CalcinosisCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

November 5, 2017

First Posted

December 4, 2017

Study Start

December 1, 2017

Primary Completion

November 1, 2018

Study Completion

December 1, 2018

Last Updated

December 4, 2017

Record last verified: 2017-10